XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Net Sales:    
Total net sales $ 15,968,729 $ 9,308,063
Cost of sales:    
Total cost of sales 9,358,272 3,784,901
Gross profit 6,610,457 5,523,162
Operating expenses:    
Research and development 1,107,736 901,144
Selling, general and administrative 4,158,903 3,006,819
Total operating expenses 5,266,639 3,907,963
Operating income 1,343,818 1,615,199
Interest expense (427,149) (360,013)
Interest income 5,250 79,479
Other income 6 17,699
Income before income taxes 921,925 1,352,364
Income tax expense (benefit) 185,733 295,014
Net income $ 736,192 $ 1,057,350
Net income per common share:    
Basic (in dollars per share) $ 0.04 $ 0.06
Diluted (in dollars per share) $ 0.04 $ 0.06
Weighted average shares outstanding:    
Basic (in shares) 17,514,193 17,451,362
Diluted(in shares) 17,584,037 17,474,906
Product    
Net Sales:    
Total net sales $ 9,984,234 $ 4,424,108
Cost of sales:    
Total cost of sales 6,262,690 1,781,345
Services    
Net Sales:    
Total net sales 5,984,495 4,883,955
Cost of sales:    
Total cost of sales $ 3,095,582 $ 2,003,556